Sensei Biotherapeutics, Inc. (SNSE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | -4.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 132.96M | 0 | -4.85M | 0 | 0 | 139K | 140K | 135K | 137K | 135K | 455K | 491K |
| COGS % of Revenue | - | - | 100% | - | - | - | - | - | - | - | - | - |
| Gross Profit | -132.96M | 0 | 0 | 0 | 0 | -139K | -140K | -135K | -137K | -135K | -455K | -491K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | 100% | 100% | 100% | -2.96% | 69.23% | 72.51% | - | 71.22% | -0.89% | -11.59% |
| Operating Expenses | 37.67M | 4.96M | 4.85M | 5.21M | 7.27M | 7.18M | 7.68M | 7.65M | 8.59M | 8.01M | 7.28M | 9.69M |
| OpEx % of Revenue | - | - | -100% | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 19.71M | 2.79M | 2.31M | 2.67M | 3.55M | 2.69M | 3.05M | 3.07M | 3.68M | 3.51M | 3.46M | 5.21M |
| SG&A % of Revenue | - | - | -47.72% | - | - | - | - | - | - | - | - | - |
| Research & Development | 17.96M | 2.17M | 2.54M | 2.53M | 3.73M | 4.49M | 4.64M | 4.58M | 4.92M | 4.49M | 3.82M | 4.48M |
| R&D % of Revenue | - | - | -52.28% | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -170.63M | -4.96M | -4.85M | -5.21M | -7.27M | -7.32M | -7.82M | -7.79M | -8.73M | -8.14M | -7.74M | -10.19M |
| Operating Margin % | - | - | 100% | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -2245.71% | 32.31% | 37.99% | 33.15% | 16.68% | 10.06% | -1.11% | 23.54% | 20.69% | 32.04% | 44.5% | 4.92% |
| EBITDA | -170.63M | -4.92M | -4.82M | -5.17M | -7.24M | -7.18M | -7.68M | -7.65M | -8.59M | -8.01M | -7.28M | -9.69M |
| EBITDA Margin % | - | - | 99.3% | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -2256.73% | 31.47% | 37.3% | 32.45% | 15.75% | 10.28% | -5.51% | 21.06% | 19.31% | 30.44% | 46.02% | 5.63% |
| D&A (Non-Cash Add-back) | 0 | 34K | 34K | 37K | 34K | 139K | 140K | 135K | 137K | 135K | 455K | 491K |
| EBIT | -170.63M | -4.71M | -4.56M | -4.93M | -6.85M | -7.75M | -7.23M | -7.12M | -7.96M | -7.38M | -7.09M | -9.35M |
| Net Interest Income | 0 | 220K | 283K | 311K | 392K | 505K | 570K | 645K | 740K | 795K | 844K | 914K |
| Interest Income | 0 | 223K | 289K | 321K | 405K | 522K | 591K | 669K | 768K | 826K | 877K | 952K |
| Interest Expense | 0 | 3K | 6K | 10K | 13K | 17K | 21K | 24K | 28K | 31K | 33K | 38K |
| Other Income/Expense | 391K | 240K | 282K | 270K | 410K | -447K | 570K | 645K | 738K | 728K | 613K | 799K |
| Pretax Income | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M |
| Pretax Margin % | - | - | 94.19% | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M |
| Net Margin % | - | - | 94.19% | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -2380.13% | 39.29% | 37.01% | 30.89% | 14.11% | -4.8% | -1.81% | 23.91% | 21.47% | 39.39% | 46.9% | 10.91% |
| Net Income (Continuing) | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -131.45 | -8.92 | -3.62 | -3.91 | -0.27 | -0.31 | -0.29 | -0.28 | -0.32 | -0.30 | -0.28 | -0.31 |
| EPS Growth % | -48585.19% | -2777.42% | -1148.28% | -1296.43% | 15.63% | -3.33% | -3.57% | 9.68% | 3.03% | 25% | 33.33% | 8.82% |
| EPS (Basic) | -131.45 | -8.92 | -3.62 | -3.91 | -0.27 | -0.31 | -0.29 | -0.28 | -0.32 | -0.30 | -0.28 | -0.31 |
| Diluted Shares Outstanding | 1.3M | 1.26M | 1.26M | 1.26M | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M |
| Basic Shares Outstanding | 1.3M | 1.26M | 1.26M | 1.26M | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |